Related Experiment Videos
Diagnosis of diffuse hepatocellular diseases using SPECT
Summary
Quantitative spleen-to-liver ratios using SPECT imaging can help diagnose liver diseases. Elevated ratios effectively differentiate liver cirrhosis from healthy individuals, aiding in scintigraphic diagnosis.
Area of Science:
- Nuclear Medicine
- Medical Imaging
- Hepatology
Background:
- Splenic uptake of colloids and splenomegaly are key scintigraphic indicators of diffuse hepatocellular diseases.
- Quantifying these changes is crucial for accurate diagnosis and disease assessment.
Purpose of the Study:
- To quantify liver and spleen volume and activity using Single Photon Emission Computed Tomography (SPECT).
- To establish spleen-to-liver (S/L) ratios for diagnosing diffuse hepatocellular diseases.
- To differentiate between liver cirrhosis and chronic hepatitis using these quantitative parameters.
Main Methods:
- SPECT imaging was utilized to measure liver and spleen volumes and activities.
- Spleen-to-liver (S/L) ratios for volume, activity, and activity/volume were calculated.
- Normal limits for S/L ratios were established (volume: 0.19, activity: 0.087, activity/volume: 0.72).
Main Results:
- Ninety-six percent of liver cirrhosis patients exhibited at least two elevated S/L ratios.
- Three elevated S/L ratios effectively distinguished liver cirrhosis patients from normal individuals.
- Only 32% of chronic hepatitis patients showed any elevation in S/L ratios.
Conclusions:
- Quantitative SPECT-derived S/L ratios are valuable for diagnosing liver cirrhosis.
- These ratios show promise in differentiating liver cirrhosis from chronic hepatitis.
- Abnormal activity/volume S/L ratios require further investigation for clearer visualization.